- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07700407
Preventing Overdose and Promoting Recovery Through Court Navigation (POPCORN)
10. Juli 2026 aktualisiert von: Bradley Ray, RTI International
Hybrid Type I Trial of a Peer-Led Court Navigation Program to Improve Substance Use Disorder Treatment Receipt and Reduce Overdose and Incarceration Among People Passing Through Courthouses
This project is a hybrid type I clinical trial to assess the effectiveness and implementation determinants of a peer-led court navigation program for people who use drugs and are passing through county courthouses.
Courthouses are a common point of contact for people with behavioral health needs, but outside of specialty court models, they remain underexplored as a setting for connecting people to substance use disorder treatment and related services.
This study will test whether court navigation led by peer recovery specialists can increase receipt of substance use disorder treatment and reduce overdose and incarceration.
Peer court navigators will meet with participants in courthouse settings, assess their needs, provide information and referrals, and offer follow-up support for up to 3 months.
Peer recovery specialists, who have lived experience with substance use recovery, are increasingly being integrated into criminal legal and community-based settings; however, peer-led court navigation remains an innovative and understudied approach.
Studienübersicht
Status
Noch keine Rekrutierung
Bedingungen
Intervention / Behandlung
Studientyp
Interventionell
Einschreibung (Geschätzt)
600
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Bradley Ray, PhD
- Telefonnummer: 919-324-5492
- E-Mail: bradleyray@rti.org
Studieren Sie die Kontaktsicherung
- Name: Cari Megerian, MPH
- Telefonnummer: 415-412-0830
- E-Mail: cmegerian@rti.org
Studienorte
-
-
Indiana
-
South Bend, Indiana, Vereinigte Staaten, 46601
- St. Joseph County Courthouse 1
-
Kontakt:
- Bradley Ray, PhD
- Telefonnummer: 919-324-5492
- E-Mail: bradleyray@rti.org
-
Kontakt:
- Cari Megerian, MPH
- Telefonnummer: 415-412-0830
- E-Mail: cmegerian@rti.org
-
-
North Carolina
-
Research Triangle Park, North Carolina, Vereinigte Staaten, 27709
- RTI International
-
Kontakt:
- Bradley Ray, PhD
- Telefonnummer: 919-324-5492
- E-Mail: bradleyray@rti.org
-
Kontakt:
- Cari Megerian, MPH
- Telefonnummer: 415-412-0830
- E-Mail: cmegerian@rti.org
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Nein
Beschreibung
Inclusion Criteria:
- Aged 18 years or older
- Current resident of Indiana
- Able to complete study procedures in English
- Meets at least one of the following criteria: used heroin, fentanyl, methamphetamine, or cocaine in the past 12 months; is interested in resources or treatment for a substance use disorder; or experienced an opioid-related overdose in the past 12 months
Exclusion Criteria:
- Has been sentenced to incarceration in jail or prison for the next 12 months
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Peer court navigation
CourtConnect is the intervention.
It connects individuals in courthouses with peer court navigators who provide information, referrals, and support to address substance use disorder treatment needs and related health and social needs.
Navigation begins in the courthouse and continues in the community through follow-up support for up to 3 months.
|
CourtConnect connects individuals in courthouses with peer court navigators who provide information, referrals, and support to address substance use disorder treatment needs and related health and social needs.
Navigation begins in the courthouse and continues in the community through follow-up support for up to 3 months.
|
|
Aktiver Komparator: Information only
Participants assigned to the information-only group receive information about health and social services in the community from a non-peer research assistant.
They do not receive peer court navigation or follow-up support from a peer court navigator.
|
Participants assigned to the information-only group receive information about health and social services in the community from a non-peer research assistant.
They do not receive peer court navigation or follow-up support from a peer court navigator.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Administratively documented substance use disorder treatment engagement
Zeitfenster: 90 days after baseline
|
This participant-level outcome will indicate whether a participant has any administratively documented substance use disorder treatment engagement within 90 days after baseline.
Treatment engagement will be determined from linked state administrative records, including Medicaid claims for substance use disorder treatment services and prescription drug monitoring program records showing dispensed medications used to treat substance use disorder.
For participants without administratively documented substance use disorder treatment during the 90 days before baseline, a qualifying post-baseline record will be classified as treatment initiation.
For participants with administratively documented substance use disorder treatment during the 90 days before baseline, a qualifying post-baseline record will be classified as continued treatment engagement.
The outcome will be reported as the proportion of participants in each study arm with administratively documented treatment engagement.
|
90 days after baseline
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Number of participants with a fatal or nonfatal overdose
Zeitfenster: 12 months after baseline
|
Fatal and nonfatal overdose will be measured using statewide vital records and emergency medical records from ambulance services and hospital emergency departments.
Participants will be classified as having experienced an overdose if records show a fatal overdose or an encounter for a nonfatal overdose during the 12 months after baseline.
|
12 months after baseline
|
|
Number of participants with a jail booking or prison entry
Zeitfenster: 12 months after baseline
|
Incarceration through jail booking or prison entry will be measured using statewide criminal legal records.
Participants will be classified as having experienced incarceration if records show a booking into a jail facility or entry into the state prison system during the 12 months after baseline.
|
12 months after baseline
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Mitarbeiter
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Geschätzt)
1. Oktober 2026
Primärer Abschluss (Geschätzt)
1. Dezember 2028
Studienabschluss (Geschätzt)
1. Mai 2030
Studienanmeldedaten
Zuerst eingereicht
3. Juli 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
10. Juli 2026
Zuerst gepostet (Tatsächlich)
14. Juli 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
14. Juli 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
10. Juli 2026
Zuletzt verifiziert
1. Juli 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- R01DA064492 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
JA
Beschreibung des IPD-Plans
The investigators will enroll 600 subjects over 24 months with 12 months of follow-up data by linking administrative records (e.g., prescription fills, emergency department/emergency medical services encounters, mortality, arrests/jail bookings) to survey contents that will include demographics, substance use disorder and treatment history, criminal legal system involvement, social constructs (self-efficacy, motivation, stigma), and harmonized measures.
The National Institutes of Health requires that the study team release study data.
The investigators will preserve and share de-identified survey datasets (with codebooks), and project documentation (protocols, instruments); derived variables from linked administrative data will be shared, while raw state administrative source files obtained under data use agreements will not be shared.
The publicly released scientific data will include only fully de-identified data.
IPD-Sharing-Zeitrahmen
IPD and additional supporting information will be archived in the National Addiction & HIV Data Archive Program (NAHDAP), assigned persistent identifiers, and made available as soon as possible and no later than the earlier of the primary publication or the end of the performance period, whichever comes first.
IPD-Sharing-Zugriffskriterien
After project completion, only de-identified datasets will be made available as public-use files and deposited in repositories for broader research, teaching, replication.
Shared data will be provided in open, non-proprietary formats, along with parallel Stata/R scripts and a README so that no specialized software is required to access or manipulate the data.
Publicly shared datasets will receive a DOI to facilitate sharing, citation, and version control.
Access will be controlled when there is any non-trivial re-identification risk or when required by data use agreements.
In those cases, repositories will gate access under standard data use agreements that prohibit re-identification and onward sharing, require secure storage and destruction at project end, and log requestor credentials and approved uses.
Raw state administrative source files received under data use agreements will not be shared; only de-identified, derived variables constructed from those sources will be deposited.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- ANALYTIC_CODE
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .